Sperm survival test could make IVF safer by spotting toxic lab tools
NCT ID NCT05100784
First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This study checks whether a test using human sperm can reliably detect toxic chemicals in the plastic dishes and tubes used for in vitro fertilization (IVF). Researchers will compare sperm movement after contact with different batches of IVF supplies. The goal is to see if this simple test can replace or supplement the current mouse embryo test, helping clinics avoid materials that might harm embryos.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Human Sperm Survival Assay (HSSA) testing on IVF consumables
- What this could lead to
- If successful, this test could become a standard quality check for IVF supplies, reducing the risk of toxic materials harming embryos.
- What could go wrong
- This is an observational study, not a treatment trial. The test may not be sensitive enough to catch all toxic batches, and results may vary across labs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
826 people
The number who actually took part.
- Started
-
Mar 2021
- Finished
-
Jan 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Male between 18 and 65 years-old with normal spermogram
- Ages
-
18 to 65 years
- Sex
-
Male participants only
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Male over 18 years-old * Normal spermogram (concentration ≥15 million / ml or total count\> 39 million, progressive mobility ≥32% or total mobility ≥40%) * Progressive mobility ≥70% after selection * Total number of progressive motile spermatozoa recovered after TMS\> 10 million * Patient affiliated or beneficiary of a social security scheme * Patient having been informed and not opposing to this research. Exclusion Criteria: * Male over 65 years-old * Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Embryotoxicity are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Private Hospital of Parly II-Le Chesnay
Le Chesnay, 78150, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists probe RNA clues to unlock IVF success for women with low egg supply
- Does vitamin d boost IVF success? new study investigates
- IVF patients get video lessons on meds — and it may ease their stress
- Talking it out: psychological help may calm nerves before egg retrieval
- IVF breakthrough? trial tests embryo 'Defrag' to boost pregnancy chances
- Yoga may ease IVF stress, new study hopes to prove